Gene Therapy for GA: VOY-101

Omer Trivizki, MD, MBA

Show Description +

Dr. Trivizki shares the first-in-human results of treatment with VOY-101 (Perceive Biotherapeutics), a complement-modulating gene therapy for geographic atrophy.

Posted: 9/18/2025

Keywords:

retina-meeting-recap

•

Gene Therapy

•

Geographic Atrophy (GA)

•

VOY-101

•

Perceive Biotherapeutics

•

complement

•

complement

•

complement factors

Up Next

Name: Gene Therapy for GA: VOY-101
Uploaded: 2025-09-18T15:41:28+00:00
Description: Dr. Trivizki shares the first-in-human results of treatment with VOY-101 (Perceive Biotherapeutics), a complement-modulating gene therapy for geographic atrophy.

Assessing Function in Dry AMD

Stela Vujosevic, MD, PhD

Extending Treatment Durability in Wet AMD

Sandrine Zweifel, MD, PhD

Wet AMD: The Promise of Gene Therapy

Arshad M. Khanani, MD, MA

Euretina Keynote: Old Techniques Made New

Maria H. Berrocal, MD

Suprachoroidal Buckling Tips and Tricks

Ehab El-Rayes, MD, PhD

Pearls for IOFB Removal

Jean-François Korobelnik, MD, PhD

Treating Macular Edema Secondary to Inflammation

Charles C. Wykoff, MD, PhD

Neovascularization in Myopic Eyes

Gemmy Cheung, MBBS, FRCOphth, FAMS, MCI

The Latest Therapies for DR

Sobha Sivaprasad, MBBS, MS, DM, FRCS, FRCOphth

Back to All Videos

Gene Therapy for GA: VOY-101

Omer Trivizki, MD, MBA

Dr. Trivizki shares the first-in-human results of treatment with VOY-101 (Perceive Biotherapeutics), a complement-modulating gene therapy for geographic atrophy.

Posted: 9/18/2025

Keywords:

retina-meeting-recap

•

Gene Therapy

•

Geographic Atrophy (GA)

•

VOY-101

•

Perceive Biotherapeutics

•

complement

•

complement

•

complement factors

Please log in to leave a comment.

Meeting Coverage:

EURETINA Congress

Gene Therapy for GA: VOY-101

Up Next

Gene Therapy for GA: VOY-101

More From EURETINA: 2025 Coverage